SYNOVUS FINANCIAL CORP
Company Information
Industry National Commercial Banks
SIC Code 6021
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation United States
Business Address 33 W 14TH STREET, COLUMBUS, GA, 31901
Mailing Address 33 W 14TH STREET, COLUMBUS, GA, 31901
Phone 7066416500
Fiscal Year End 1231
EIN 581134883
Financial Overview
FY2024
$757.90M
Net Income
$60.23B
Total Assets
$5.24B
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
Material Events
8-K Other December 8, 2025
Medium Impact
- SYNOVUS FINANCIAL CORP announced it will present at the Goldman Sachs 2025 US Financial Services Conference.
- The company made its presentation materials publicly available on Monday, December 8, 2025.
Related Companies
Companies in the same industry (SIC: 6021)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.